<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="5fe9c118-c44b-48d7-a142-9668ae3df0c6"><labelDrug name="Effient"><Normalization><mmtx cui="C2718746" preferredWord="Effient" semType="phsu, orch"/></Normalization></labelDrug><generic name="Prasugrel hydrochloride"/><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.1" text="Drug Label for drug brand Effient, containing Prasugrel hydrochloride." type="negative"><entity charOffset="0:19" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.1.e.0" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Effient," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="26:33" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.1.e.1" text="effient" type="Biomedical_Entity"><Normalization><mmtx cui="C2718746" phraseText="Drug Label for drug brand Effient," preferredWord="Effient" semType="phsu, orch"/><RxNorm RxCui="855813"/></Normalization></entity><entity charOffset="46:69" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.1.e.2" text="prasugrel hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C2683417" phraseText="Prasugrel hydrochloride." preferredWord="prasugrel hydrochloride" semType="phsu, orch"/><RxNorm RxCui="847020"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.1.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.1.e.1"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.1.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.1.e.2"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.1.e.1" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.1.e.2"/></sentence><sentence biomedicalEntities="0" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.8" lineNumber="11" text="Additional risk factors for bleeding include:" type="irregular"><entity charOffset="28:36" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.8.e.1" text="bleeding" type="Specific_Interaction"/><drugInteraction id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.8.ddi.1"><interaction trigger="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.8.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.7" text="When possible, discontinue Effient at least 7 days prior to any surgery."><entity charOffset="27:34" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.7.e.0" text="Effient" type="Drug"><Normalization><mmtx cui="C2718746" phraseText="Effient at least 7 days" preferredWord="Effient" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.11.e.1"/></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.11" text="&lt;item&gt;concomitant use of medications that increase the risk of bleeding (e.g., warfarin, heparin, fibrinolytic therapy, chronic use of non-steroidal anti-inflammatory drugs NSAIDs )" type="negative"><entity charOffset="135:179" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.11.e.0" text="non-steroidal anti-inflammatory drugs nsaids" type="Biomedical_Entity"><Normalization><mmtx cui="C0003211" phraseText="chronic use of non-steroidal anti-inflammatory drugs NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="79:87" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.11.e.1" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="warfarin," preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="89:96" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.11.e.2" text="heparin" type="Biomedical_Entity"><Normalization><mmtx cui="C0019134" phraseText="heparin," preferredWord="Heparin" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.11.e.1" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.11.e.0"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.11.e.2" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.11.e.0"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.11.e.1" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.11.e.2"/></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.24" text="Stopping Effient, particularly in the first few weeks after acute coronary syndrome, increases the risk of subsequent cardiovascular events (5.3)." type="negative"><entity charOffset="0:8" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.24.e.0" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="Stopping Effient," preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><entity charOffset="9:16" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.24.e.1" text="effient" type="Biomedical_Entity"><Normalization><mmtx cui="C2718746" phraseText="Stopping Effient," preferredWord="Effient" semType="phsu, orch"/><RxNorm RxCui="855813"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.24.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.24.e.1"/></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.33" text="In TRITON-TIMI 38 (TR ial to Assess I mprovement in T herapeutic Outcomes by O ptimizing Platelet InhibitioN with Prasugrel), patients with a history of TIA or ischemic stroke ( 3 months prior to enrollment) had a higher rate of stroke on Effient (6.5%, of which 4.2% were thrombotic stroke and 2.3% were intracranial hemorrhage ICH ) than on clopidogrel (1.2%, all thrombotic). " type="negative"><entity charOffset="343:354" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.33.e.0" text="clopidogrel" type="Biomedical_Entity"><Normalization><mmtx cui="C0070166" phraseText="on clopidogrel" preferredWord="clopidogrel" semType="phsu, orch"/><RxNorm RxCui="236991"/></Normalization></entity><entity charOffset="239:246" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.33.e.1" text="effient" type="Biomedical_Entity"><Normalization><mmtx cui="C2718746" phraseText="on Effient" preferredWord="Effient" semType="phsu, orch"/><RxNorm RxCui="855813"/></Normalization></entity><entity charOffset="114:123" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.33.e.2" text="prasugrel" type="Biomedical_Entity"><Normalization><mmtx cui="C1620287" phraseText="with Prasugrel" preferredWord="prasugrel" semType="phsu, orch"/><RxNorm RxCui="847020"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.33.e.1" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.33.e.0"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.33.e.2" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.33.e.0"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.33.e.2" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.33.e.1"/></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.34" text="In patients without such a history, the incidence of stroke was 0.9% (0.2% ICH) and 1.0% (0.3% ICH) with Effient and clopidogrel, respectively. " type="negative"><entity charOffset="105:112" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.34.e.0" text="effient" type="Biomedical_Entity"><Normalization><mmtx cui="C2718746" phraseText="(0.3% ICH) with Effient" preferredWord="Effient" semType="phsu, orch"/><RxNorm RxCui="855813"/></Normalization></entity><entity charOffset="117:128" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.34.e.1" text="clopidogrel" type="Biomedical_Entity"><Normalization><mmtx cui="C0070166" phraseText="clopidogrel," preferredWord="clopidogrel" semType="phsu, orch"/><RxNorm RxCui="236991"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.34.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.34.e.1"/></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.38" text="Effient is contraindicated in patients with hypersensitivity (e.g., anaphylaxis) to prasugrel or any component of the product see Adverse Reactions (6.2)." type="negative"><entity charOffset="0:7" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.38.e.0" text="effient" type="Biomedical_Entity"><Normalization><mmtx cui="C2718746" phraseText="Effient" preferredWord="Effient" semType="phsu, orch"/><RxNorm RxCui="855813"/></Normalization></entity><entity charOffset="84:93" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.38.e.1" text="prasugrel" type="Biomedical_Entity"><Normalization><mmtx cui="C1620287" phraseText="to prasugrel" preferredWord="prasugrel" semType="phsu, orch"/><RxNorm RxCui="847020"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.38.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.38.e.1"/></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.43" text="&lt;item&gt;Hypersensitivity: Hypersensitivity including angioedema has been reported with Effient including in patients with a history of hypersensitivity reaction to other thienopyridines (5.5)." type="negative"><entity charOffset="85:92" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.43.e.0" text="effient" type="Biomedical_Entity"><Normalization><mmtx cui="C2718746" phraseText="reported with Effient" preferredWord="Effient" semType="phsu, orch"/><RxNorm RxCui="855813"/></Normalization></entity><entity charOffset="168:183" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.43.e.1" text="thienopyridines" type="Biomedical_Entity"><Normalization><mmtx cui="C1120149" phraseText="to other thienopyridines" preferredWord="thienopyridine" semType="phsu, orch"/><RxNorm RxCui="1031667"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.43.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.43.e.1"/></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.45" text="Thienopyridines, including Effient, increase the risk of bleeding. " type="negative"><entity charOffset="27:34" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.45.e.0" text="effient" type="Biomedical_Entity"><Normalization><mmtx cui="C2718746" phraseText="Effient," preferredWord="Effient" semType="phsu, orch"/><RxNorm RxCui="855813"/></Normalization></entity><entity charOffset="0:15" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.45.e.1" text="thienopyridines" type="Biomedical_Entity"><Normalization><mmtx cui="C1120149" phraseText="Thienopyridines," preferredWord="thienopyridine" semType="phsu, orch"/><RxNorm RxCui="1031667"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.45.e.1" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.45.e.0"/></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.46" text="With the dosing regimens used in TRITON-TIMI 38, TIMI (Thrombolysis in Myocardial Infarction) Major (clinically overt bleeding associated with a fall in hemoglobin 5 g/dL, or intracranial hemorrhage) and TIMI Minor (overt bleeding associated with a fall in hemoglobin of 3 g/dL but 5 g/dL) bleeding events were more common on Effient than on clopidogrel see Adverse Reactions (6.1). " type="negative"><entity charOffset="55:67" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.46.e.0" text="thrombolysis" type="Biomedical_Entity"><Normalization><mmtx cui="C0016018" phraseText="TIMI (Thrombolysis in Myocardial Infarction" preferredWord="Fibrinolytic Agents" semType="phsu"/><RxNorm RxCui="986448"/></Normalization></entity><entity charOffset="342:353" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.46.e.1" text="clopidogrel" type="Biomedical_Entity"><Normalization><mmtx cui="C0070166" phraseText="on clopidogrel" preferredWord="clopidogrel" semType="phsu, orch"/><RxNorm RxCui="236991"/></Normalization></entity><entity charOffset="326:333" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.46.e.2" text="effient" type="Biomedical_Entity"><Normalization><mmtx cui="C2718746" phraseText="more common on Effient" preferredWord="Effient" semType="phsu, orch"/><RxNorm RxCui="855813"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.46.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.46.e.1"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.46.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.46.e.2"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.46.e.2" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.46.e.1"/></sentence><sentence biomedicalEntities="0" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.50" lineNumber="88" text="Other risk factors for bleeding are:" type="irregular"><entity charOffset="23:31" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.50.e.1" text="bleeding" type="Specific_Interaction"/><drugInteraction id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.50.ddi.1"><interaction trigger="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.50.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.57.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.49" text="Do not use Effient in patients with active bleeding, prior TIA or stroke see Contraindications (4.1 and 4.2)."><entity charOffset="11:18" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.49.e.0" text="Effient" type="Drug"><Normalization><mmtx cui="C2718746" phraseText="Effient in patients" preferredWord="Effient" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.57" text="&lt;item&gt;Medications that increase the risk of bleeding (e.g., oral anticoagulants, chronic use of non-steroidal anti-inflammatory drugs NSAIDs, and fibrinolytic agents). " type="negative"><entity charOffset="146:165" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.57.e.0" text="fibrinolytic agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0016018" phraseText="fibrinolytic agents" preferredWord="Fibrinolytic Agents" semType="phsu"/><RxNorm RxCui="934"/></Normalization></entity><entity charOffset="60:79" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.57.e.1" text="oral anticoagulants" type="Biomedical_Entity"><Normalization><mmtx cui="C0354604" phraseText="oral anticoagulants," preferredWord="Anticoagulants, Oral" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="96:140" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.57.e.2" text="non-steroidal anti-inflammatory drugs nsaids" type="Biomedical_Entity"><Normalization><mmtx cui="C0003211" phraseText="chronic use of non-steroidal anti-inflammatory drugs NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.57.e.1" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.57.e.0"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.57.e.2" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.57.e.0"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.57.e.1" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.57.e.2"/></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.58" text="Aspirin and heparin were commonly used in TRITON-TIMI 38 see Drug Interactions (7), Clinical Studies (14)." type="negative"><entity charOffset="0:7" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.58.e.0" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="Aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="12:19" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.58.e.1" text="heparin" type="Biomedical_Entity"><Normalization><mmtx cui="C0770546" phraseText="heparin" preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.58.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.58.e.1"/></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.66" text="Of the 437 patients who underwent CABG during TRITON-TIMI 38, the rates of CABG-related TIMI Major or Minor bleeding were 14.1% in the Effient group and 4.5% in the clopidogrel group see Adverse Reactions (6.1). " type="negative"><entity charOffset="165:176" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.66.e.0" text="clopidogrel" type="Biomedical_Entity"><Normalization><mmtx cui="C0070166" phraseText="4.5% in the clopidogrel group" preferredWord="clopidogrel" semType="phsu, orch"/><RxNorm RxCui="236991"/></Normalization></entity><entity charOffset="135:142" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.66.e.1" text="effient" type="Biomedical_Entity"><Normalization><mmtx cui="C2718746" phraseText="14.1% in the Effient group" preferredWord="Effient" semType="phsu, orch"/><RxNorm RxCui="855813"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.66.e.1" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.66.e.0"/></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.68" text="For patients receiving a thienopyridine within 3 days prior to CABG, the frequencies of TIMI Major or Minor bleeding were 26.7% (12 of 45 patients) in the Effient group, compared with 5.0% (3 of 60 patients) in the clopidogrel group. " type="negative"><entity charOffset="215:226" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.68.e.0" text="clopidogrel" type="Biomedical_Entity"><Normalization><mmtx cui="C0070166" phraseText="in the clopidogrel group." preferredWord="clopidogrel" semType="phsu, orch"/><RxNorm RxCui="236991"/></Normalization></entity><entity charOffset="155:162" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.68.e.1" text="effient" type="Biomedical_Entity"><Normalization><mmtx cui="C2718746" phraseText="in the Effient group," preferredWord="Effient" semType="phsu, orch"/><RxNorm RxCui="855813"/></Normalization></entity><entity charOffset="25:39" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.68.e.2" text="thienopyridine" type="Biomedical_Entity"><Normalization><mmtx cui="C1120149" phraseText="a thienopyridine within 3 days" preferredWord="thienopyridine" semType="phsu, orch"/><RxNorm RxCui="1031667"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.68.e.1" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.68.e.0"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.68.e.2" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.68.e.0"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.68.e.2" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.68.e.1"/></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.69" text="For patients who received their last dose of thienopyridine within 4 to 7 days prior to CABG, the frequencies decreased to 11.3% (9 of 80 patients) in the prasugrel group and 3.4% (3 of 89 patients) in the clopidogrel group." type="negative"><entity charOffset="155:164" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.69.e.0" text="prasugrel" type="Biomedical_Entity"><Normalization><mmtx cui="C1620287" phraseText="in the prasugrel group" preferredWord="prasugrel" semType="phsu, orch"/><RxNorm RxCui="847020"/></Normalization></entity><entity charOffset="45:59" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.69.e.1" text="thienopyridine" type="Biomedical_Entity"><Normalization><mmtx cui="C1120149" phraseText="their last dose of thienopyridine" preferredWord="thienopyridine" semType="phsu, orch"/><RxNorm RxCui="1031667"/></Normalization></entity><entity charOffset="206:217" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.69.e.2" text="clopidogrel" type="Biomedical_Entity"><Normalization><mmtx cui="C0070166" phraseText="in the clopidogrel group." preferredWord="clopidogrel" semType="phsu, orch"/><RxNorm RxCui="236991"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.69.e.1" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.69.e.0"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.69.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.69.e.2"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.69.e.1" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.69.e.2"/></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.71" text="CABG-related bleeding may be treated with transfusion of blood products, including packed red blood cells and platelets, however, platelet transfusions within 6 hours of the loading dose or 4 hours of the maintenance dose may be less effective." type="negative"><entity charOffset="83:105" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.71.e.0" text="packed red blood cells" type="Biomedical_Entity"><Normalization><mmtx cui="C2316467" phraseText="packed red blood cells" preferredWord="Packed red blood cells" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="57:71" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.71.e.1" text="blood products" type="Biomedical_Entity"><Normalization><mmtx cui="C0456388" phraseText="treated with transfusion of blood products," preferredWord="Blood product" semType="phsu"/><RxNorm RxCui="1629"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.71.e.1" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.71.e.0"/></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.73" text="Discontinue thienopyridines, including Effient, for active bleeding, elective surgery, stroke, or TIA. " type="negative"><entity charOffset="12:27" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.73.e.0" text="thienopyridines" type="Biomedical_Entity"><Normalization><mmtx cui="C1120149" phraseText="thienopyridines," preferredWord="thienopyridine" semType="phsu, orch"/><RxNorm RxCui="1031667"/></Normalization></entity><entity charOffset="39:46" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.73.e.1" text="effient" type="Biomedical_Entity"><Normalization><mmtx cui="C2718746" phraseText="Effient," preferredWord="Effient" semType="phsu, orch"/><RxNorm RxCui="855813"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.73.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.73.e.1"/></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.84" text="Hypersensitivity including angioedema has been reported in patients receiving Effient, including patients with a history of hypersensitivity reaction to other thienopyridines see Contraindications (4.3), Adverse Reactions (6.2)." type="negative"><entity charOffset="78:85" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.84.e.0" text="effient" type="Biomedical_Entity"><Normalization><mmtx cui="C2718746" phraseText="Effient," preferredWord="Effient" semType="phsu, orch"/><RxNorm RxCui="855813"/></Normalization></entity><entity charOffset="159:174" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.84.e.1" text="thienopyridines" type="Biomedical_Entity"><Normalization><mmtx cui="C1120149" phraseText="to other thienopyridines" preferredWord="thienopyridine" semType="phsu, orch"/><RxNorm RxCui="1031667"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.84.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.84.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.87" lineNumber="131" text="Coadministration of Effient and warfarin increases the risk of bleeding see Warnings and Precautions (5.1) and Clinical Pharmacology (12.3)." type="regular"><entity charOffset="63:71" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.87.e.1" text="bleeding" type="Specific_Interaction"/><entity charOffset="20:27" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.87.e.2" text="Effient" type="Drug"><Normalization><mmtx cui="C2718746" phraseText="Coadministration of Effient" preferredWord="Effient" semType="phsu, orch"/><RxNorm RxCui="855813"/></Normalization></entity><entity charOffset="32:40" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.87.e.3" text="warfarin" type="Drug"><Normalization><mmtx cui="C0043031" phraseText="warfarin" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><drugInteraction id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.87.ddi.1"><interaction trigger="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.87.e.1"><relations><relation type="hasObject"><entity id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.87.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.87.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.87.e.2" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.87.e.3" trigger="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.87.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.89" lineNumber="135" text="Coadministration of Effient and NSAIDs (used chronically) may increase the risk of bleeding see Warnings and Precautions (5.1)." type="regular"><entity charOffset="83:91" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.89.e.1" text="bleeding" type="Specific_Interaction"/><entity charOffset="32:38" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.89.e.2" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="20:27" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.89.e.3" text="Effient" type="Drug"><Normalization><mmtx cui="C2718746" phraseText="Coadministration of Effient" preferredWord="Effient" semType="phsu, orch"/><RxNorm RxCui="855813"/></Normalization></entity><drugInteraction id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.89.ddi.1"><interaction trigger="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.89.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.89.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.89.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.89.e.3" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.89.e.2" trigger="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.89.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.91" text="Effient can be administered with drugs that are inducers or inhibitors of cytochrome P450 enzymes see Clinical Pharmacology (12.3)." type="negative"><entity charOffset="0:7" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.91.e.0" text="effient" type="Biomedical_Entity"><Normalization><mmtx cui="C2718746" phraseText="Effient" preferredWord="Effient" semType="phsu, orch"/><RxNorm RxCui="855813"/></Normalization></entity><entity charOffset="60:97" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.91.e.1" text="inhibitors enzymes" type="Biomedical_Entity"><Normalization><mmtx cui="C0014432" phraseText="inhibitors of cytochrome P450 enzymes" preferredWord="Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.91.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.91.e.1"/></sentence><sentence id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92" text="Effient can be administered with aspirin (75 mg to 325 mg per day), heparin, GPIIb/IIIa inhibitors, statins, digoxin, and drugs that elevate gastric pH, including proton pump inhibitors and H2 blockers see Clinical Pharmacology (12.3)." type="negative"><entity charOffset="0:7" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.0" text="effient" type="Biomedical_Entity"><Normalization><mmtx cui="C2718746" phraseText="Effient" preferredWord="Effient" semType="phsu, orch"/><RxNorm RxCui="855813"/></Normalization></entity><entity charOffset="163:185" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.1" text="proton pump inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0358591" phraseText="proton pump inhibitors" preferredWord="Proton Pump Inhibitors" semType="phsu"/><RxNorm RxCui="8879"/></Normalization></entity><entity charOffset="33:40" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.2" text="aspirin" type="Biomedical_Entity"><Normalization><mmtx cui="C0004057" phraseText="administered with aspirin" preferredWord="Aspirin" semType="phsu, orch"/><RxNorm RxCui="1191"/></Normalization></entity><entity charOffset="109:116" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.3" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin," preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="68:75" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.4" text="heparin" type="Biomedical_Entity"><Normalization><mmtx cui="C0770546" phraseText="heparin," preferredWord="heparin, porcine" semType="bacs, phsu, carb"/><RxNorm RxCui="5224"/></Normalization></entity><entity charOffset="190:201" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.5" text="h2 blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0019593" phraseText="H2 blockers" preferredWord="Histamine H2 Antagonists" semType="phsu"/><RxNorm RxCui="34748"/></Normalization></entity><entity charOffset="100:107" id="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.6" text="statins" type="Biomedical_Entity"><Normalization><mmtx cui="C0360714" phraseText="statins," preferredWord="Hydroxymethylglutaryl-CoA Reductase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="108229"/></Normalization></entity><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.1"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.2"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.3"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.4"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.5"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.0" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.6"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.2" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.1"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.3" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.1"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.4" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.1"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.1" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.5"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.6" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.1"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.2" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.3"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.2" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.4"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.2" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.5"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.2" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.6"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.4" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.3"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.3" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.5"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.6" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.3"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.4" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.5"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.4" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.6"/><pair ddi="false" e1="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.6" e2="Dailymed.5fe9c118-c44b-48d7-a142-9668ae3df0c6.s.92.e.5"/></sentence><positiveExamples number="2"/><negativeExamples number="53"/></document>